Vernalis to raise £68.5m 10/02/2012
Drug discoverer Vernalis (VER) is to raise £68.5 million as part of a joint venture with US concern Tris Pharma.
Turnaround investment specialist Volvere is not about to ‘pile into deals’ after turning £178,000 annual losses into £525,000 pre-tax profits.
That is the message from a cautious Jonathan Lander, chief executive officer of the AIM–quoted company, which more than trebled turnover to £10.9 million overall last year but had a poor second half. He remains wary about ‘leaping into deals’ until the financial outlook becomes clearer.
Lander points out ‘we were not prepared to pay what Jon Moulton did for Reader’s Digest’, referring to the £13 million rescue of the ailing publishing group by private equity luminary Moulton’s Better Capital. The company has instead been putting money into banks’ preference shares and various debt instruments ‘yielding between 9 and 12 per cent’.
In 2009, Volvere, chaired by former retail tycoon and ex-Tory party treasurer Lord Kalms, increased profits, including those from discontinued operations, from £509,000 to £7.2 million, while net assets rose 57 per cent to £18.2 million. However, the full-year figures show a deterioration, partly caused by accounting conventions, from those achieved in the first half, when Volvere made £587,000 pre-tax or £7.8 million including discontinued operations on £5.4 million turnover and achieved net assets of £19.4 million.
The company has recouped its original £1.3 million investment in its key holding, marketing and data services concern Interactive Prospect Targeting (IPT), whose profits quadrupled to £1.7 million last year. Volvere sold its Sira certification business for a minimum £8.1 million, while Sira Defence & Security made progress, supplying monitoring software to government, police and the military.
Volvere’s tightly held and volatile shares, which have traded between 340p and 144.5p over the past year, now stand at 275p, down 27.5p. That values the company at £14.5 million.
Subscribe today and save 50%. Receive company watch recommendations and extensive company profile tips, released two months ahead of the market.
Advertisement
£100 credit when you open five trades within 60 days – terms apply. Spread Trading is not for everyone please ensure you understand the risks as you may lose more than your initial deposit. Click here for more information.
This unique study analyses the shareholdings of companies listed on AIM, extracting trends including rankings of the value and number of their investments.
Please click here to order your copy of the report or call 0207 250 7056.
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
If you're interested in business tax updates visit our specialist tax guide website.
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
Advertisement
Drug discoverer Vernalis (VER) is to raise £68.5 million as part of a joint venture with US concern Tris Pharma.
Magnolia Petroleum (MAGP) has acquired 800 acres in the Mississippi Lime formation in Oklahoma.
Gold explorer Condor Resources (CNR) has reported encouraging results from drilling at its La India project in Nicaragua.
US-focused Nighthawk Energy is launching a $7.5 million program to invest in its Colorado-based Jolly Ranch project.
Africa-focused Tower Resources (TRP) has raised £5.4 million via a placing with a mixture of institutional investors and directors.
Beleaguered travel operator Thomas Cook (TCG) has reported a loss of £91 million its first quarter also announcing the sale of its Indian division.